Who We Are

Canna Global Investments PLC (CGI PLC) is an agricultural biotechnology, investment and brands company with an extreme Impact Investing Ecosystem ethos. We focus on researching, developing, investing in and licensing sustainable medical cannabis and hemp products and their derived intellectual property. Our clients will have the confidence in knowing that our products will be free of harmful chemicals, metals, bacterial pathogens and microbiological contaminants. CGI PLC has a management team with deep expertise across R&D, product development, cannabis investing verticals, technology, sales and finance. Our ultimate vision is to create material shareholder value while advancing cannabanoid research & development or cheaper sustainable drugs.

Aims & Objectives
To be one of the World’s largest licensed producers of cannabis seed, medicinal extracts, and related products
To be one of the World's leading exporters of cannabis flower and its derived extracts into regulated global markets
To build successful commercial cultivation facilities and recognisable brands in a rapidly growing industry


Promising Research – Cannabis Potentially Blocks COVID-19

Canna Global Investments Plc. has identified promising research with preliminary evidence that cannabis can potentially block the COVID-19 infection.

  10/2/2020 11:13:56 PM
Medical cannabis product approved for epilepsy

The EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy.

  9/24/2019 4:53:41 AM

Medical marijuana: Fastest growing industry in USA with $7 out of $10 spent on it.

Cannabis Europa: Focus on entry to the UK cannabis market though Africa.

CGI PLC is creating a portfolio of cannabis and hemp-related Intellectual Property assets that meet clear commercial needs which offer our shareholders best-in-class returns. CGI’s long term strategy is to be the global leader in the production of medical, recreational cannabinoid extracts, oils, nutraceuticals, and pharmaceuticals with a solid set of highly developed IP assets. These assets will be licensed to companies capable of delivering our revolutionary cannabis based products to the global market place.

Contact Us

Devonshire House, 1st Floor, 1 Mayfair Place,
London, W1J 8AJ, United Kingdom
Email: info@cgiplc.co.uk